Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety
Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.
Read more on NPR
Health Care
September 26, 2020 at 05:18AM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét